JP2020533313A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533313A5
JP2020533313A5 JP2020513814A JP2020513814A JP2020533313A5 JP 2020533313 A5 JP2020533313 A5 JP 2020533313A5 JP 2020513814 A JP2020513814 A JP 2020513814A JP 2020513814 A JP2020513814 A JP 2020513814A JP 2020533313 A5 JP2020533313 A5 JP 2020533313A5
Authority
JP
Japan
Prior art keywords
aav
vector
tissue
group
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020513814A
Other languages
English (en)
Japanese (ja)
Other versions
JP7291125B2 (ja
JP2020533313A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/049914 external-priority patent/WO2019051202A1/en
Publication of JP2020533313A publication Critical patent/JP2020533313A/ja
Publication of JP2020533313A5 publication Critical patent/JP2020533313A5/ja
Priority to JP2023065365A priority Critical patent/JP2023089148A/ja
Application granted granted Critical
Publication of JP7291125B2 publication Critical patent/JP7291125B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020513814A 2017-09-08 2018-09-07 神経障害性疼痛を処置するための方法および組成物 Active JP7291125B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023065365A JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762556088P 2017-09-08 2017-09-08
US62/556,088 2017-09-08
PCT/US2018/049914 WO2019051202A1 (en) 2017-09-08 2018-09-07 METHOD AND COMPOSITION FOR TREATING NEUROPATHIC PAIN

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023065365A Division JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2020533313A JP2020533313A (ja) 2020-11-19
JP2020533313A5 true JP2020533313A5 (enExample) 2021-09-30
JP7291125B2 JP7291125B2 (ja) 2023-06-14

Family

ID=65634388

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020513814A Active JP7291125B2 (ja) 2017-09-08 2018-09-07 神経障害性疼痛を処置するための方法および組成物
JP2023065365A Pending JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023065365A Pending JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Country Status (8)

Country Link
US (1) US11707535B2 (enExample)
EP (1) EP3678709A4 (enExample)
JP (2) JP7291125B2 (enExample)
KR (1) KR102640462B1 (enExample)
CN (1) CN111093716B (enExample)
AU (1) AU2018327253B2 (enExample)
CA (1) CA3074587A1 (enExample)
WO (1) WO2019051202A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023389530A1 (en) * 2022-12-05 2025-07-03 Eg 427 Viral vector encoding gad for treating spasticity

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292722A (en) 1992-11-06 1994-03-08 Brigham And Women's Hospital Intravenous solution that diminishes body protein loss
US5643286A (en) 1994-06-24 1997-07-01 Cytotherapeutics, Inc. Microdrive for use in stereotactic surgery
US20020007145A1 (en) 1998-10-23 2002-01-17 Timothy Stivland Catheter having improved bonding region
JP2003530131A (ja) 1999-03-07 2003-10-14 ディスクレ リミテッド コンピューターを利用する手術方法及び装置
WO2001073015A1 (en) * 2000-03-27 2001-10-04 Merck Patent Gmbh Identification of human gaba transporter
WO2002020753A2 (en) 2000-09-01 2002-03-14 Lexicon Genetics Incorporated Human gaba transporter protein and polynucleotides encoding the same
US7011647B2 (en) 2001-07-13 2006-03-14 Scimed Life Systems, Inc. Introducer sheath
EP1805213B1 (en) * 2004-10-28 2015-11-18 University of Pittsburgh - Of the Commonwealth System of Higher Education Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
ATE524121T1 (de) 2004-11-24 2011-09-15 Abdou Samy Vorrichtungen zur platzierung eines orthopädischen intervertebralen implantats
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
KR20080007968A (ko) 2006-07-19 2008-01-23 연세대학교 산학협력단 Ｇａｄ65를 발현하는 재조합 벡터를 포함하는 신경병증성통증 완화용 조성물
WO2008010637A1 (en) * 2006-07-19 2008-01-24 Industry-Academic Cooperation Foundation, Yonsei University Composition for attenuating neuropathic pain comprising a recombinant vector expressing gad65
SI2497500T1 (sl) 2006-10-03 2017-01-31 Genzyme Corporation Genska terapija za spinalno mišično atrofijo
WO2008112177A2 (en) 2007-03-08 2008-09-18 Genizon Biosciences, Inc. Genemap of the human genes associated with schizophrenia
WO2009091514A2 (en) 2008-01-14 2009-07-23 I-V Access Technology, Inc. An apparatus for peripheral vascular access
WO2009124244A1 (en) 2008-04-04 2009-10-08 The Cleveland Clinic Foundation Spinal platform and method for delivering a therapeutic agent to a spinal cord target
WO2010071832A1 (en) 2008-12-19 2010-06-24 Nationwide Children's Hospital Delivery of polynucleotides across the blood brain barrier using recombinant aav9
CN102666856B (zh) 2009-11-08 2016-04-06 夸克制药公司 定向至RhoA靶基因的双链RNA化合物在制造治疗神经性疼痛的药物中的用途
WO2012050907A2 (en) 2010-09-28 2012-04-19 The Regents Of The University Of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes
CA2819635A1 (en) 2010-12-01 2012-06-07 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
CN107982548A (zh) 2012-02-07 2018-05-04 全球生物疗法有限公司 核酸输送的区室化方法及其组合物和应用
CA2896442A1 (en) 2012-09-24 2014-03-27 The Regents Of The University Of California Spinal cord pulsation-cancelation injection system
CA2898617A1 (en) * 2013-01-23 2014-07-31 The Regents Of The University Of California Method and composition for treating spasticity
GB201308917D0 (en) 2013-05-17 2013-07-03 Renishaw Plc Delivery
EP3250279B1 (en) 2015-01-30 2020-08-19 The Regents of the University of California Spinal subpial gene delivery system
US10688285B2 (en) 2015-01-30 2020-06-23 The Regents Of The University Of California Spinal subpial gene delivery system
KR20170034701A (ko) * 2015-09-21 2017-03-29 코오롱생명과학 주식회사 통증 치료용 조성물
JP6949867B2 (ja) 2016-03-28 2021-10-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ 神経の過剰興奮を治療するための方法および組成物

Similar Documents

Publication Publication Date Title
JP7395550B2 (ja) 新規アデノ随伴ウイルスキャプシドタンパク質
JP2021106619A5 (enExample)
JP2020522269A5 (enExample)
IL292999A (en) Compositions and methods of treating amyotrophic lateral sclerosis (als)
JP2020019772A5 (enExample)
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
RU2017115477A (ru) Полинуклеотиды aadc для лечения болезни паркинсона
AU2019250249A1 (en) Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
IL275880B1 (en) Gene therapy for limb-girdle muscular dystrophy type 2c
JP2017535266A5 (enExample)
JP2007507223A5 (enExample)
JP2020519284A5 (enExample)
JP2017529395A5 (enExample)
JPWO2020106916A5 (enExample)
CA3158518A1 (en) Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseases
JPWO2019153009A5 (enExample)
JPWO2021053222A5 (enExample)
JPWO2020214609A5 (enExample)
JP2020533313A5 (enExample)
FI3177313T3 (fi) Telomeraasi-käänteistranskriptaasipohjaisia hoitoja sydäninfarktiin liittyvien tilojen hoitamiseksi
JPWO2019222354A5 (enExample)
NZ761563B2 (en) Method and composition for treating neuropathic pain
NZ761563A (en) Method and composition for treating neuropathic pain
JPWO2022028472A5 (enExample)
JPWO2021222168A5 (enExample)